A more likely and near term price range than the previous thread heading - http://www.cnbc.com/id/102531646 I'm taking advantage and averaging down now. Hopefully win back some losses.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%